Hôpital Européen Georges Pompidou (HEGP)
Hôpital Européen Georges Pompidou (HEGP)
Paris, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vortosiran for VTE Prevention | Embolism, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, cancer, cardiovascular disorder, disease, lung disorder, neoplasm, pulmonary embolism, respiratory system disorder, vascular disorder, venous thromboembolism | Not yet recruiting | Phase 2 | 2026-09-30 | NCT07850453 | |
| Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 4 | 2026-07-01 | NCT04790370 | |
| Trial on Radical Upfront Surgery in Advanced Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Not applicable | 2025-10-03 | NCT02828618 |